Trafficking of dopamine transporters in psychostimulant actions

Seminars in Cell and Developmental Biology

Volumn 20, Issue 4, 2009, Pages 411-417

  Zahniser, Nancy R ^a   Sorkin, Alexander ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Cocaine; Dopamine transporter regulation; Endocytosis; Review

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; METHYLPHENIDATE; NICOTINE; PSYCHOSTIMULANT AGENT;

CELL MEMBRANE; CELL SURFACE; DRUG ACTIVITY; DRUG BINDING; DRUG DEPENDENCE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; NEUROTRANSMISSION; NONHUMAN; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; UPREGULATION;

ANIMALIA;

EID: 67649252642     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2009.01.004     Document Type: Review

References (79)

1. Yokel R.A., and Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187 (1975) 547-549
2. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162 (2005) 1403-1413
3. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29 (2006) 565-598
4. Berridge K.C. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 191 (2007) 391-431
5. Di Chiara G., and Bassareo V. Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7 (2007) 69-76
6. Volkow N.D., Fowler J.S., and Wang G.J. Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behav Pharmacol 13 (2002) 355-366
7. Pierce R.C., and Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev 30 (2006) 215-238
8. Roesch M.R., Takahashi Y., Gugsa N., Bissonette G.B., and Schoenbaum G. Previous cocaine exposure makes rats hypersensitive to both delay and reward magnitude. J Neurosci 27 (2007) 245-250
9. Everitt B.J., and Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8 (2005) 1481-1489
10. Volkow N.D., Wang G.J., Telang F., Fowler J.S., Logan J., Childress A.R., et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26 (2006) 6583-6588
11. See R.E., Elliott J.C., and Feltenstein M.W. The role of dorsal vs ventral striatal pathways in cocaine-seeking behavior after prolonged abstinence in rats. Psychopharmacology 194 (2007) 321-331
12. Belin D., and Everitt B.J. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57 (2008) 432-441
13. Nirenberg M., Vaughan R., Uhl G., Kuhar M., and Pickel V. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16 (1996) 436-447
14. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
15. Chen N.H., Reith M.E., and Quick M.W. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch 447 (2004) 519-531
16. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14 (1991) 299-302
17. Chen R., Tilley M.R., Wei H., Zhou F., Zhou F.M., Ching S., et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103 (2006) 9333-9338
18. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., and Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47 (2007) 681-698
19. --dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92 (2001) 21-55
20. Zahniser N.R., and Sorkin A. Rapid regulation of the dopamine transporter: role in stimulant addiction?. Neuropharmacology 47 Suppl. 1 (2004) 80-91
21. Mortensen O.V., and Amara S.G. Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479 (2003) 159-170
22. Li L.B., Chen N., Ramamoorthy S., Chi L., Cui X.N., Wang L.C., et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem 279 (2004) 21012-21020
23. Hersch S.M., Yi H., Heilman C.J., Edwards R.H., and Levey A.I. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388 (1997) 211-227
24. Lin Z., Wang W., and Uhl G.R. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains. Mol Pharmacol 58 (2000) 1581-1592
25. Torres G.E., Carneiro A., Seamans K., Fiorentini C., Sweeney A., Yao W.D., et al. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278 (2003) 2731-2739
26. Sorkina T., Doolen S., Galperin E., Zahniser N.R., and Sorkin A. Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J Biol Chem 278 (2003) 28274-28283
27. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., et al. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30 (2001) 121-134
28. Bjerggaard C., Fog J.U., Hastrup H., Madsen K., Loland C.J., Javitch J.A., et al. Surface targeting of the dopamine transporter involves discrete epitopes in the distal C terminus but does not require canonical PDZ domain interactions. J Neurosci 24 (2004) 7024-7036
29. Miranda M., Sorkina T., Grammatopoulos T.N., Zawada W.M., and Sorkin A. Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. J Biol Chem 279 (2004) 30760-30770
30. Sorkina T., Hoover B.R., Zahniser N.R., and Sorkin A. Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6 (2005) 157-170
31. Barlowe C. Signals for COPII-dependent export from the ER: what's the ticket out?. Trends Cell Biol 13 (2003) 295-300
32. Nirenberg M.J., Chan J., Pohorille A., Vaughan R.A., Uhl G.R., Kuhar M.J., et al. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17 (1997) 6899-6907
33. Gu H.H., Wu X., Giros B., Caron M.G., Caplan M.J., and Rudnick G. The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells. Mol Biol Cell 12 (2001) 3797-3807
34. McDonald P.W., Hardie S.L., Jessen T.N., Carvelli L., Matthies D.S., and Blakely R.D. Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. J Neurosci 27 (2007) 14216-14227
35. Zhu S.-J., Kavanaugh M.P., Sonders M.S., Amara S.G., and Zahniser N.R. Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus Oocytes. J Pharmacol Exp Ther 282 (1997) 1358-1365
36. Pristupa Z.B., McConkey F., Liu F., Man H.Y., Lee F.J., Wang Y.T., et al. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30 (1998) 79-87
37. Daniels G.M., and Amara S.G. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274 (1999) 35794-35801
38. Melikian H.E., and Buckley K.M. Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19 (1999) 7699-7710
39. Loder M.K., and Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J Biol Chem 278 (2003) 22168-22174
40. Sorkina T., Miranda M., Dionne K.R., Hoover B.R., Zahniser N.R., and Sorkin A. RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis. J Neurosci 26 (2006) 8195-8205
41. Foster J.D., Adkins S.D., Lever J.R., and Vaughan R.A. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 105 (2008) 1683-1699
42. Granas C., Ferrer J., Loland C.J., Javitch J.A., and Gether U. N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278 (2003) 4990-5000
43. Miranda M., Wu C.C., Sorkina T., Korstjens D.R., and Sorkin A. Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C. J Biol Chem 280 (2005) 35617-35624
44. Miranda M., Dionne K.R., Sorkina T., and Sorkin A. Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter. Mol Biol Cell 18 (2007) 313-323
45. Holton K.L., Loder M.K., and Melikian H.E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat Neurosci 8 (2005) 881-888
46. Chi L., and Reith M.E. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Ther 307 (2003) 729-736
47. Hoover B.R., Everett C.V., Sorkin A., and Zahniser N.R. Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J Neurochem 101 (2007) 1258-1271
48. Mortensen O.V., Larsen M.B., Prasad B.M., and Amara S.G. Genetic complementation screen identifies a map kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking. Mol Biol Cell 19 (2008) 2818-2829
49. Doolen S., and Zahniser N.R. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther 296 (2001) 931-938
50. Moron J.A., Zakharova I., Ferrer J.V., Merrill G.A., Hope B., Lafer E.M., et al. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23 (2003) 8480-8488
51. Bolan E.A., Kivell B., Jaligam V., Oz M., Jayanthi L.D., Han Y., et al. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71 (2007) 1222-1232
52. Zapata A., Kivell B., Han Y., Javitch J.A., Bolan E.A., Kuraguntla D., et al. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem 282 (2007) 35842-35854
53. Carneiro A.M., Ingram S.L., Beaulieu J.M., Sweeney A., Amara S.G., Thomas S.M., et al. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci 22 (2002) 7045-7054
54. Lee F.J., Liu F., Pristupa Z.B., and Niznik H.B. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15 (2001) 916-926
55. Wersinger C., and Sidhu A. Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett 340 (2003) 189-192
56. Qian J.J., Cheng Y.B., Yang Y.P., Mao C.J., Qin Z.H., Li K., et al. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP(+)-induced neurotoxicity in PC12 cells. Neurosci Lett 435 (2008) 142-146
57. Cen X., Nitta A., Ibi D., Zhao Y., Niwa M., Taguchi K., et al. Identification of Piccolo as a regulator of behavioral plasticity and dopamine transporter internalization. Mol Psychiatry 13 349 (2008) 451-463
58. Marazziti D., Mandillo S., Di Pietro C., Golini E., Matteoni R., and Tocchini-Valentini G.P. GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. Proc Natl Acad Sci U S A 104 (2007) 9846-9851
59. Middleton L.S., Apparsundaram S., King-Pospisil K.A., and Dwoskin L.P. Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism. Eur J Pharmacol 554 (2007) 128-136
60. Riddle E.L., Topham M.K., Haycock J.W., Hanson G.R., and Fleckenstein A.E. Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur J Pharmacol 449 (2002) 71-74
61. Fleckenstein A.E., Metzger R.R., Wilkins D.G., Gibb J.W., and Hanson G.R. Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282 (1997) 834-838
62. Sandoval V., Riddle E.L., Ugarte Y.V., Hanson G.R., and Fleckenstein A.E. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21 (2001) 1413-1419
63. Kokoshka J.M., Vaughan R.A., Hanson G.R., and Fleckenstein A.E. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 361 (1998) 269-275
64. Gulley J.M., Doolen S., and Zahniser N.R. Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83 (2002) 400-411
65. Thwar P.K., Guptaroy B., Zhang M., Gnegy M.E., Burns M.A., and Linderman J.J. Simple transporter trafficking model for amphetamine-induced dopamine efflux. Synapse 61 (2007) 500-514
66. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A 97 (2000) 6850-6855
67. Kahlig K.M., Javitch J.A., and Galli A. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J Biol Chem 279 (2004) 8966-8975
68. Kahlig K.M., Lute B.J., Wei Y., Loland C.J., Gether U., Javitch J.A., et al. Regulation of dopamine transporter trafficking by intracellular amphetamine. Mol Pharmacol 70 (2006) 542-548
69. Garcia B., Wei Y., Moron J.A., Lin R.Z., Javitch J.A., and Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell surface redistribution. Mol Pharmacol 68 (2005) 102-109
70. Wei Y., Williams J.M., Dipace C., Sung U., Javitch J.A., Galli A., et al. Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol 71 (2007) 835-842
71. Boudanova E., Navaroli D.M., and Melikian H.E. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54 (2008) 605-612
72. Johnson L.A., Furman C.A., Zhang M., Guptaroy B., and Gnegy M.E. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49 (2005) 750-758
73. Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., and Mash D.C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 271 (1994) 1678-1685
74. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., and Izenwasser S. Dopamine transport function is elevated in cocaine users. J Neurochem 81 (2002) 292-300
75. Little K.Y., Elmer L.W., Zhong H., Scheys J.O., and Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61 (2002) 436-445
76. Daws L.C., Callaghan P.D., Moron J.A., Kahlig K.M., Shippenberg T.S., Javitch J.A., et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290 (2002) 1545-1550
77. Loland C.J., Desai R.I., Zou M.F., Cao J., Grundt P., Gerstbrein K., et al. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73 (2008) 813-823
78. Samuvel D.J., Jayanthi L.D., Manohar S., Kaliyaperumal K., See R.E., and Ramamoorthy S. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens. J Pharmacol Exp Ther 325 (2008) 293-301
79. Yamashita A., Singh S.K., Kawate T., Jin Y., and Gouaux E. Crystal structure of a bacterial homologue of Na(+)/Cl(-)-dependent neurotransmitter transporters. Nature 437 (2005) 215-223